Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Identification of Genes Connected with the Sensitivity to 5-FU and Cisplatin in Squamous Cell Carcinoma Cell Lines

´ëÇѱ¸°­³»°úÇÐȸÁö 2005³â 30±Ç 3È£ p.287 ~ 300
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ³ª¿µ ±è¿ÁÁØ/À̱ݼ÷/±èº´±¹/±èÀçÇü/ÀåÀ±¿µ/ÀÓ¿øºÀ/Á¤¹Î¾Æ/ÃÖÈ«¶õ

Abstract

µÎ°æºÎ¿¡¼­ ¹ß»ýÇÏ´Â ÆíÆò¼¼Æ÷¾ÏÁ¾Àº °°Àº Á¶Á÷ÇÐÀû ºÐ·ù, Á¶Á÷ÇÐÀû ´Ü°è ¹× ÀÓ»ó ´Ü°è¿¡ ÀÖ´ÙÇÏ´õ¶óµµ Ç×¾ÏÁ¦ Åõ¿©¿¡ µû¸¥ °¨¼ö¼ºÀº ȯÀÚ¸¶´Ù ´Ù¾çÇÏ°Ô ³ªÅ¸³­´Ù. µû¶ó¼­, º» ¿¬±¸ÀÇ ¸ñÀûÀº ±âÁ¸¿¡ °¡Àå ¸¹ÀÌ »ç¿ëÇÏ´Â Ç×¾ÏÁ¦ÀÎ 5-FU ¿Í CisplatinÀÇ °¨¼ö¼ºÀ» ¿¹ÃøÇÒ ¼ö ÀÖ´Â »ý¹°ÇÐÀû Ç¥ÁöÀÚ¸¦ ã¾Æ ȯÀÚ¿¡°Ô ¸Â´Â Ç×¾ÏÁ¦¸¦ ¼±ÅÃÇϱâ À§Çؼ­ÀÌ´Ù.
5Á¾ÀÇ ±¸°­ ÆíÆò¾Ï¼¼Æ÷¾ÏÁÖ¸¦ ÀÌ¿ëÇÏ¿´À¸¸ç, 5-FU ¿Í CisplatinÀÇ Ç×¾ÏÁ¦ °¨¼ö¼ºÀ» ÃøÁ¤Çϱâ À§ÇØ MTT assay¸¦ ½ÃÇàÇÏ¿´´Ù. °¢ ¼¼Æ÷ ÁÖÀÇ Àü RNA¸¦ ÃßÃâÇÏ¿´À¸¸ç À̾ cDNA¸¦ ÇÕ¼ºÇÏ¿´´Ù. ´Ù¾çÇÑ À¯ÀüÀÚ¸¦ 1) µ¹¿¬º¯ÀÌ 2) ¿°Áõ(COX pathway) 3) ¼¼Æ÷ÁÖ±â 4) ³ëÈ­ 5) ¼¼Æ÷¿Ü±âÁú °ú °ü·ÃµÇ°Ô ºÐ·ùÇÏ¿´°í RT-PCRÀ» ½ÃÇàÇÏ¿© À¯ÀüÀÚÀÇ ¹ßÇö·®À» »ìÆ캸¾Ò´Ù. °á°ú¹°Àº Scion image ÇÁ·Î±×·¥À» ÅëÇØ ºÐ¼®ÇÏ¿´°í, Sigma plotÀ» ÀÌ¿ëÇØ Ç¥½ÃÇÏ¿´´Ù.
5-FUÀÇ °¨¼ö¼º°ú ºñ·ÊÇÏ´Â À¯ÀüÀÚµéÀº XPA, XPC, OGG, APEX, COX-2, PPAR, Cyclin E, Cyclin B1, CDC2, hTERT, hTR, TIMP-3, TIMP-4 ¹× HSP47À̾úÀ¸¸ç, CisplatinÀÇ °¨¼ö¼º°ú ºñ·ÊÇÏ´Â À¯ÀüÀÚµéÀº COX-1, iNOS, eNOS, PCNA, Col-1 ¹× MMP-9 À¸·Î ¾Ë ¼ö ÀÖ¾ú´Ù.
À§ °á°ú´Â ¾ÏȯÀÚ¿¡°Ô ¾Ë¸ÂÀº Ç×¾ÏÁ¦¸¦ ¼±Åà ½Ã Ç×¾ÏÁ¦ÀÇ °¨¼ö¼º°ú °ü·ÃÇÑ À¯ÀüÀÚµéÀÇ ¹ßÇö Á¤µµ¸¦ ÆľÇÇÑ´Ù¸é ¿Ã¹Ù¸¥ Ç×¾ÏÁ¦¸¦ ¼±ÅÃÇϴµ¥ µµ¿òÀÌ µÇ¸®¶ó »ç·áµÈ´Ù.

Squamous cell carcinoma (SCC) in head and neck show a variability in the response to chemotherapy, even when it present with similar histological tumor type, grade, and clinical stage. The purpose of present study it to identify predictive bio-marker for the sensitivity or resistance to conventional chemotherapeutic agents, 5-fluorouracil (5-FU) and Cisplatin.
Oral cancer cell lines were used in present study. MTT assay was performed to evaluate the sensitivity and/or resistance to 5-FU and Cisplatin. And RT-PCR was carried out for evaluation of the mRNA expressions of various genes associated with mutation, inflammation (COX pathway), cell cycle, senescence and extracellular matrix (ECM).
The molecules which are correlated with the sensitivity to 5-FU are XPA, XPC, OGG, APEX, COX-2, PPAR, Cyclin E, Cyclin B1, CDC2, hTERT, hTR, TIMP-3, TIMP-4 and HSP47. And the molecules are correlated with the sensitivity to Cisplatin are COX-1, iNOS, eNOS, PCNA, collagen 1 and MMP-9.
Taken together, when choosing the appropriate chemotherpeutic agents for patients, considering the molecules which are correlated or reversely correlated is helpful to choose the resonable agents for cancer patients.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI